The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved in pain signaling.

The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non ...

Stock picks in the healthcare sector have been among the strongest over White’s tenure and include companies such as Teladoc TDOC and HCA Healthcare HCA. He bought Teladoc in late 2018 and sold ...